Millavelez, Chriz June .

HRN: 21-85-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
CEFTRIAXONE 1G (VIAL)
08/23/2022
08/30/2022
IV
1 G
Q12H
T/CNephrotic Syndrome; R/O Strep Infection
Waiting Final Action 
11/03/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/03/2022
11/09/2022
IV DRIP
700 Mg
Q6
Acute Bacterial Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: